Acute liver necrosis induced by iodine-131-MIBG in the treatment of metastatic carcinoid tumors.
J Nucl Med
; 38(7): 1024-6, 1997 Jul.
Article
en En
| MEDLINE
| ID: mdl-9225784
ABSTRACT
Iodine-131-metaiodobenzylguanidine (MIBG) is used in the treatment of carcinoid tumors. Temporary palliation with complete subjective symptomatic response has been reported in these patients. This treatment is usually well tolerated and side-effects are generally limited to nausea, mild hepatic toxicity with spontaneous recovery and temporary myelosuppression. Our case report shows that repeated treatment with [131I]MIBG in a patient with extensive carcinoid liver metastasis may cause severe hepatic toxicity leading to death. Factors such as concomitant use of 5-fluorouracil and the progressive nature of the disease may have contributed to this event.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Tumor Carcinoide
/
Radioisótopos de Yodo
/
Yodobencenos
/
Hígado
/
Neoplasias Hepáticas
Límite:
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
J Nucl Med
Año:
1997
Tipo del documento:
Article
País de afiliación:
Países Bajos